Clinical Trial Update: Study of Varenicline (Champix) for Smoking Cessation/Reduction in Patients With Bipolar Disorder [NA]

View source ↗

Summary

A completed clinical trial tested varenicline for smoking cessation in patients with bipolar disorder and nicotine dependence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Nicotine Dependence

Drugs mentioned

• Varenicline (varenicline)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Nicotine Dependence | NA | Status: COMPLETED